Cherry Tree Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Cherry Tree Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$523	Hold	1	–	–	﹤0.01%	556
2026 Q2	$527	Hold	1	–	–	﹤0.01%	568
2026 Q1	$562	Hold	1	–	–	﹤0.01%	560
2025 Q4	$677	Hold	1	–	–	﹤0.01%	562
2025 Q3	$639	Hold	1	–	–	﹤0.01%	559
2025 Q2	$537	Hold	1	–	–	﹤0.01%	581
2025 Q1	$420	Hold	1	–	–	﹤0.01%	733
2024 Q4	$414	Hold	1	–	–	﹤0.01%	618
2024 Q3	$506	Hold	1	–	–	﹤0.01%	590
2024 Q2	$488	Hold	1	–	–	﹤0.01%	573
2024 Q1	$540	Hold	1	–	–	﹤0.01%	569
2023 Q4	$556	Hold	1	–	–	﹤0.01%	564
2023 Q3	$438	Hold	1	–	–	﹤0.01%	562
2023 Q2	$503	Buy	+1	New	+$479	﹤0.01%	562

Other funds holding IDXX

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.8B AUM 9.05% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return

Mogy Joel R Investment Counsel Beverly Hills, California $1.87B AUM 18.64% 1-Year Est. Return

Cherry Tree Wealth Management's IDXX Position: Q3 2026 in Review

Cherry Tree Wealth Management held its Idexx Laboratories (IDXX) position steady in Q3 2026 at 1 share worth $523. The position accounts for ﹤0.01% of the portfolio, ranked #556.

Cherry Tree Wealth Management first reported a position in IDXX in Q2 2023 and has held it in 14 quarters since. The position peaked at $677 in Q4 2025. 389 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

Cherry Tree Wealth Management held 1 share of Idexx Laboratories worth $523 as of Q3 2026.
Cherry Tree Wealth Management left its Idexx Laboratories share count unchanged in Q3 2026.
Idexx Laboratories made up ﹤0.01% of Cherry Tree Wealth Management's portfolio in Q3 2026, its #556 holding.
Cherry Tree Wealth Management first reported a position in Idexx Laboratories in Q2 2023 and has held it in 14 quarters since.
Cherry Tree Wealth Management's Idexx Laboratories position peaked at $677 in Q4 2025.
389 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Cherry Tree Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.